Meeting Overview
0+
Industry Speaker
0+
Professional Visitors
10+
Special Topic
2+
Featured Event
Highlights
- •BPD USA and BIOCHINA USA are working in tandem to cover the full value chain from business development through R&D, CMC, and manufacturing.
- •A one-stop global industry platform for exhibitors to facilitate technical collaboration, business partnerships, and networking.
Schedule Content
6 21
Venue 1 - CMC Innovation Development
09:30-10:10
09:30-09:50
New CMC Development Platform for Rapid ADC Deployment Based on TMALIN
Zhou Weiqiang (CTO, MediLink Therapeutics)
09:50-10:10
Global Regulatory CMC Modernization and Partner Collaboration
Hong Fei (Chief Consultant, StellarHealth Consulting)
10:10-10:55
10:10-10:55
Interview: Building a Competitive CMC System from Regulatory, Data, and Quality Perspectives
Moderator: Gao Shan (SVP of CMC, Bright Peak Therapeutics); Guests: Zhang Tao (Senior Director, Gilead Sciences), Hu Wenbing (VP of CMC, Bambusa Therapeutics), Zhang Xiang (Former CSO, Ambrx), Bai Yunling (Vice President, WuXi Biologics)
10:55-11:35
10:55-11:15
Revolutionary Coupling Technology for ADC CMC Development and GMP Manufacturing
Qu Amy (GeneQuantum Healthcare CTO)
11:15-11:35
Strategies for Scaling Up iPSC Therapy Manufacturing and Process Optimization
Fan Jing (Founder & CEO, Hopstem Therapeutics)
11:35-11:55
11:35-11:55
How to Build and Manage CDMO Partnerships for Reliable Delivery and Consistency
Rafael Arie (Associate Director, Janux Therapeutics)
Venue 2 - New Drug Development and Innovation
13:00-13:45
13:00-13:45
Interview: How to Build a Global R&D Advantage
Guests: Qin Gang (GeneQuantum CEO), Chen Mingqiu (Biosion Founder & CEO), and Tony Chen (Phrontline Biopharma CEO)
13:45-14:25
13:45-14:05
AI-Driven Peptide Drug Discovery
Zhang Genwei (Senior Director, XtalPi)
14:05-14:25
T Cell Engager Development: From Innovation to Therapeutic Impact
Julie Bailis (Vice President, Research, Amgen Inc.)
14:25-14:45
14:25-14:45
Differentiated Design and Development of ADCs
Tony Xue (Founder & CEO, MediLink Therapeutics)
15:15-16:35
15:15-15:35
ZSP1601: Best-in-Class Novel Therapy for MASH
Chen Xiaoxin (Co-Founder/Chairman, Raynovent)
15:35-15:55
AI-Driven: Precision Design and Efficient Development of Molecular Glues
Lily Zou (Co-Founder & CEO, Degron Therapeutics Inc.)
15:55-16:15
TBD
16:15-16:35
Key Breakthrough in Oral Cyclopeptide Therapy
Jane Wang (CSO, Xintel)
